2019
DOI: 10.1016/j.anai.2018.08.024
|View full text |Cite
|
Sign up to set email alerts
|

Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation

Abstract: The molecular phenotype of AA AD skin is characterized by attenuated Th1 and Th17 but similar Th2/Th22-skewing to EA AD. Our data encourages a personalized medicine approach accounting for phenotype-specific characteristics in future development of targeted therapeutics and clinical trial design for AD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
124
1
4

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 154 publications
(133 citation statements)
references
References 73 publications
(102 reference statements)
4
124
1
4
Order By: Relevance
“…[1][2][3]11,14,38 Although AD has been long recognized as a T H 2-driven disease, recently, it has been shown to have a significant T H 22 component, 1,29,33,[55][56][57][58][59] with several clinical and molecular disease subtypes that show variable contributions of T H 1 and T H 17 and differential T H 2/ T H 22 activation. 30,32,33,[59][60][61][62][63][64][65][66][67][68][69] Crisaborole topical treatment induced significant modulation of several immune and KC pathways beyond those related to T H 2 inflammation, suggesting that this topical treatment might be broadly applicable across the AD phenotype spectrum. This notion is supported by the highly significant effects of crisaborole on measures of epidermal hyperplasia, including the IL-17/IL-22-induced S100As, which are dysregulated in all AD phenotypes.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[1][2][3]11,14,38 Although AD has been long recognized as a T H 2-driven disease, recently, it has been shown to have a significant T H 22 component, 1,29,33,[55][56][57][58][59] with several clinical and molecular disease subtypes that show variable contributions of T H 1 and T H 17 and differential T H 2/ T H 22 activation. 30,32,33,[59][60][61][62][63][64][65][66][67][68][69] Crisaborole topical treatment induced significant modulation of several immune and KC pathways beyond those related to T H 2 inflammation, suggesting that this topical treatment might be broadly applicable across the AD phenotype spectrum. This notion is supported by the highly significant effects of crisaborole on measures of epidermal hyperplasia, including the IL-17/IL-22-induced S100As, which are dysregulated in all AD phenotypes.…”
Section: Discussionmentioning
confidence: 99%
“…This notion is supported by the highly significant effects of crisaborole on measures of epidermal hyperplasia, including the IL-17/IL-22-induced S100As, which are dysregulated in all AD phenotypes. 3,30,32,33,63,68,70 Future studies in specific patient populations should evaluate whether there are any differences in therapeutic response.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A recent study that sought to characterize the global molecular profile of patients with AD found significant variation in cellular infiltrates, as well as expression of immune and barrier genes between African American and white subjects. 39 The extent to which such changes are due to environmental and behavioral factors should be explored in future work. The fact that the skin pigment PRS did not correlate with AD risk in the GERA cohort provides evidence that AD is likely independent of skin pigment per se and that the pigment difference between African American and white subjects does not explain the AD prevalence difference.…”
Section: Discussionmentioning
confidence: 99%
“…Atopic dermatitis (AD) is one of the most common inflammatory skin diseases, driven by T H 2/T H 22, with variable degrees of T H 1/T H 17 involvement in different subtypes. [1][2][3] Although most cases begin in early childhood, persistence into adulthood is common, suggesting that AD may be a life-long disease. 4,5 AD is a heterogeneous disease with various recognized endotypes based on IgE status, filaggrin mutations, and, more recently, ethnic and age-related variations.…”
Section: Introductionmentioning
confidence: 99%